Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2025)

Historic Inventory Average for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q3 2025 value amounting to $31.4 million.

  • Agios Pharmaceuticals' Inventory Average rose 2485.01% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.4 million, marking a year-over-year increase of 2485.01%. This contributed to the annual value of $23.3 million for FY2024, which is 6937.03% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Inventory Average of $31.4 million as of Q3 2025, which was up 2485.01% from $30.2 million recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Inventory Average high stood at $31.4 million for Q3 2025, and its period low was $3.3 million during Q2 2022.
  • Moreover, its 4-year median value for Inventory Average was $19.6 million (2023), whereas its average is $18.6 million.
  • Per our database at Business Quant, Agios Pharmaceuticals' Inventory Average soared by 31321.62% in 2023 and then surged by 2485.01% in 2025.
  • Over the past 4 years, Agios Pharmaceuticals' Inventory Average (Quarter) stood at $6.8 million in 2022, then soared by 165.95% to $18.2 million in 2023, then soared by 48.68% to $27.0 million in 2024, then grew by 16.35% to $31.4 million in 2025.
  • Its last three reported values are $31.4 million in Q3 2025, $30.2 million for Q2 2025, and $28.6 million during Q1 2025.